79 related articles for article (PubMed ID: 25676557)
1. Keratoacanthoma and squamous cell carcinoma are distinct from a molecular perspective.
Ra SH; Su A; Li X; Zhou J; Cochran AJ; Kulkarni RP; Binder SW
Mod Pathol; 2015 Jun; 28(6):799-806. PubMed ID: 25676557
[TBL] [Abstract][Full Text] [Related]
2. A case of multiple self-healing squamous epitheliomas of Ferguson-Smith in a patient on systemic immunosuppression for rheumatoid arthritis.
Prideaux A; Davidson L; Webber L; Hitchens E; Keith D
Clin Exp Dermatol; 2023 Nov; 48(12):1388-1390. PubMed ID: 37625788
[No Abstract] [Full Text] [Related]
3. Squamous carcinogenesis: potential truncal mutations.
Tang H; Seykora JT; Ko CJ
Hum Pathol; 2023 Oct; 140():32-38. PubMed ID: 37001739
[TBL] [Abstract][Full Text] [Related]
4. [Not Available].
Laryngorhinootologie; 2024 Jan; 103(1):71. PubMed ID: 38181777
[No Abstract] [Full Text] [Related]
5. Keratoacanthoma (KA): An update and review.
Kwiek B; Schwartz RA
J Am Acad Dermatol; 2016 Jun; 74(6):1220-33. PubMed ID: 26853179
[TBL] [Abstract][Full Text] [Related]
6. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
[TBL] [Abstract][Full Text] [Related]
7. Squamous Cell Carcinoma Arising From Keratoacanthoma: An Evaluation by RT-PCR.
Ni C; Su A; Ra S; Li X; Cochran A; Binder S
Am J Dermatopathol; 2016 Mar; 38(3):247-9. PubMed ID: 26067455
[No Abstract] [Full Text] [Related]
8. Advances in histopathological diagnosis of keratoacanthoma.
Takai T
J Dermatol; 2017 Mar; 44(3):304-314. PubMed ID: 28256761
[TBL] [Abstract][Full Text] [Related]
9. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
[TBL] [Abstract][Full Text] [Related]
10. Keratoacanthoma: a distinct entity?
Gleich T; Chiticariu E; Huber M; Hohl D
Exp Dermatol; 2016 Feb; 25(2):85-91. PubMed ID: 26476131
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells.
Puthanveetil P; Chen S; Feng B; Gautam A; Chakrabarti S
J Cell Mol Med; 2015 Jun; 19(6):1418-25. PubMed ID: 25787249
[TBL] [Abstract][Full Text] [Related]
12. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor.
Li S; Wang Q; Qiang Q; Shan H; Shi M; Chen B; Zhao S; Yuan L
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1909-20. PubMed ID: 25773124
[TBL] [Abstract][Full Text] [Related]
13. Differentiating keratoacanthoma from squamous cell carcinoma-In quest of the holy grail.
Nagarajan P
J Cutan Pathol; 2020 Apr; 47(4):418-420. PubMed ID: 31893469
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology.
Veenstra J; Ozog D; Loveless I; Adrianto I; Dimitrion P; Subedi K; Friedman BJ; Zhou L; Mi QS
J Invest Dermatol; 2023 Dec; 143(12):2397-2407.e8. PubMed ID: 37419445
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for keratoacanthoma of facial skin: A case report and review of literature.
Jia X; Ge Y; Wang H; Ma Y
Front Oncol; 2022; 12():1032090. PubMed ID: 36698402
[TBL] [Abstract][Full Text] [Related]
16. Lower lip recurrent keratoacanthoma: A case report.
Liu XG; Liu XG; Wang CJ; Wang HX; Wang XX
World J Clin Cases; 2022 Jul; 10(20):6960-6965. PubMed ID: 36051135
[TBL] [Abstract][Full Text] [Related]
17. Clinical, histopathological and immunohistochemical study of keratoacanthoma.
Vîlcea AM; Stoica LE; Georgescu CV; Popescu FC; Ciurea RN; Vîlcea ID; Mirea CS
Rom J Morphol Embryol; 2021; 62(2):445-456. PubMed ID: 35024732
[TBL] [Abstract][Full Text] [Related]
18. Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity.
da Fonseca LG; Fuster-Anglada C; Carrera C; Millán C; Samper E; Sapena V; Díaz-González Á; Sanduzzi-Zamparelli M; Leal C; Forner A; Bruix J; Reig M; Boix L; Díaz A
Oncotarget; 2021 Mar; 12(5):440-449. PubMed ID: 33747359
[TBL] [Abstract][Full Text] [Related]
19. Keratoacanthoma, committed stem cells and neoplastic aberrant infundibulogenesis integral to formulating a conceptual model for an infundibulocystic pathway to squamous cell carcinoma.
Kossard S
J Cutan Pathol; 2021 Jan; 48(1):184-191. PubMed ID: 32881028
[TBL] [Abstract][Full Text] [Related]
20. Myriad facades of keratocanthoma: Benignity VS malignancy.
Sharma P; Narwal A; Kamboj M
J Oral Biol Craniofac Res; 2019; 9(4):352-354. PubMed ID: 31667065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
